Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Bluejay Diagnostics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 6 | 8 | +2 |
| Shares | 58.8K | 216.1K | +157.3K (+267.4%) |
| Value | $108.2K | $259.3K | +$151.1K (+139.6%) |
New holders (5)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 131,000 | $157.2K | 0.00% |
| Heights Capital Management, Inc | 35,400 | $42.5K | 0.01% |
| Boothbay Fund Management, LLC | 27,130 | $32.6K | 0.00% |
| Bank of America Corp | 10,337 | $12.4K | 0.00% |
| Vanguard Fiduciary Trust Co | 10,225 | $12.3K | 0.00% |
Sold out (3)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Sabby Management, LLC | 28,726 | $52.9K |
| Geode Capital Management, LLC | 28,127 | $51.8K |
| UBS Group AG | 124 | $228 |